What is Semaglutide?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It is FDA-approved and marketed under several brand names: Ozempic and Rybelsus for type 2 diabetes, and Wegovy for chronic weight management.
Unlike most peptides discussed on this site, semaglutide is a fully approved medication. It does not depend on the 2026 compounding review, and a licensed provider can prescribe it now for patients who meet clinical criteria.
How it is thought to work
Semaglutide mimics GLP-1, a hormone the gut releases after eating. It stimulates insulin release when blood sugar is elevated, lowers glucagon, slows how quickly the stomach empties, and acts on appetite centers in the brain to reduce hunger.
The combined effect is steadier blood sugar and reduced food intake, which supports weight loss when paired with diet and activity changes.
What the research shows
Semaglutide is supported by large randomized controlled trials. Studies in type 2 diabetes and in chronic weight management have shown meaningful improvements in blood sugar and significant weight reduction.
The SELECT trial also reported a reduction in cardiovascular events among people with overweight or obesity who had established cardiovascular disease.
We summarize published research and do not make therapeutic promises. A licensed provider can evaluate whether any therapy is appropriate for you. Treat any source promising guaranteed results with skepticism.
Approved uses
- Chronic weight management in eligible adults (per approved use)
- Blood-sugar control in type 2 diabetes
- Cardiovascular risk reduction in eligible patients
Availability
Semaglutide is FDA-approved and available now by prescription. There is no need to wait on the 2026 peptide review.
Note that the drug shortage that previously allowed widespread compounding of semaglutide has largely resolved, so the standard route is the branded, approved product prescribed by a licensed provider.
How to access Semaglutide legitimately
A licensed provider reviews your history and goals and, if appropriate, prescribes the branded product through a licensed pharmacy. Dosing is typically started low and increased gradually to manage side effects.
PeptideForward can match you with vetted telehealth providers who handle these therapies through legitimate channels. The eligibility check takes about five minutes and there is no cost to see if you are a candidate.
Frequently asked questions
Is semaglutide legal to get now? Yes. It is an FDA-approved prescription medication available today through licensed providers for patients who qualify.
Is compounded semaglutide an option? With the shortage largely resolved, the standard route is the approved branded product. Compounding of GLP-1s has narrowed and is an area of active enforcement, so a provider will guide you to the appropriate option.
Does PeptideForward sell semaglutide? No. We are an education and matching service and never sell or supply any medication.